Logo

SSNC

SS&C Technologies Holdings, Inc.

SSNC

SS&C Technologies Holdings, Inc. NASDAQ
$85.94 0.28% (+0.24)

Market Cap $20.97 B
52w High $91.07
52w Low $69.61
Dividend Yield 1.02%
P/E 25.5
Volume 470.29K
Outstanding Shares 244.06M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $1.568B $382.1M $210M 13.393% $0.86 $533.5M
Q2-2025 $1.537B $392.4M $180.8M 11.765% $0.74 $519.9M
Q1-2025 $1.514B $389.2M $213M 14.07% $0.87 $537.3M
Q4-2024 $1.53B $396M $248.2M 16.225% $1.01 $539.8M
Q3-2024 $1.466B $379.1M $164.4M 11.216% $0.67 $505.5M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $390.8M $19.489B $12.505B $6.931B
Q2-2025 $2.891B $18.984B $11.975B $6.935B
Q1-2025 $4.519B $20.405B $13.545B $6.785B
Q4-2024 $3.37B $19.045B $12.436B $6.535B
Q3-2024 $2.31B $18.438B $11.55B $6.814B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $210.7M $456.2M $-81.5M $195.9M $2.977B $421.5M
Q2-2025 $180.8M $372.9M $-84.8M $-1.923B $-4.036B $350M
Q1-2025 $213.2M $272.2M $-63.3M $935.3M $1.148B $259.5M
Q4-2024 $248.4M $462.2M $-28.6M $637.8M $1.06B $592.2M
Q3-2024 $164.4M $336.5M $-718.6M $807.5M $431.6M $261.2M

Revenue by Products

Product Q3-2024Q1-2025Q2-2025Q3-2025
Maintenance And Term Licenses
Maintenance And Term Licenses
$230.00M $210.00M $230.00M $220.00M
Perpetual Licenses
Perpetual Licenses
$10.00M $10.00M $10.00M $10.00M
Professional Services
Professional Services
$20.00M $20.00M $30.00M $30.00M
Software Enabled Services
Software Enabled Services
$1.21Bn $1.27Bn $1.27Bn $1.31Bn

Five-Year Company Overview

Income Statement

Income Statement SS&C’s income statement shows a business that has grown steadily while staying solidly profitable. Revenue has increased each year, and core profitability metrics like operating profit and EBITDA have trended upward as well, suggesting the company is scaling efficiently rather than just growing for growth’s sake. Net income has been more uneven, with earnings dipping after a strong year and then recovering more recently. That pattern hints at factors like acquisition costs, interest expense, or one-time items influencing the bottom line from year to year. Overall, though, the business looks consistently profitable with improving scale, but not a perfectly smooth earnings path.


Balance Sheet

Balance Sheet The balance sheet reflects a sizable, established software and services platform. Total assets have grown over time, helped by acquisitions and ongoing investment. Cash levels have improved significantly versus earlier years, giving SS&C more flexibility than it had in the past. Debt remains meaningful and has not come down materially, so leverage is still an important consideration. However, shareholders’ equity has been rising, which supports the company’s capital base. In simple terms, SS&C carries notable debt but also has a stronger cash position and a growing equity cushion compared with earlier years.


Cash Flow

Cash Flow Cash flow is a clear strength. The company consistently generates solid cash from its operations, and that cash generation has generally grown over the period. After modest spending on capital expenditures, free cash flow remains strong, which is typical of an asset-light software and services model. The relatively low capital spending needs mean more of the earnings convert into free cash that can be used for debt service, acquisitions, or returns to shareholders. The main watchpoint is how management chooses to allocate this cash, especially given its ongoing acquisition strategy and leverage.


Competitive Edge

Competitive Edge SS&C operates from a position of meaningful strength in financial and healthcare software and services. Its platforms are deeply embedded in clients’ day-to-day operations, which makes switching providers costly, risky, and time-consuming. That “stickiness” is a key part of its moat. The company offers a broad, integrated suite that can cover front-, middle-, and back-office needs, reducing the need for clients to juggle multiple vendors. Scale, a large global network (boosted by deals like Calastone), and a long track record of integrating acquisitions further reinforce its competitive position. The flip side is ongoing exposure to intense competition from other large fintech and software firms, as well as execution risk when absorbing new acquisitions.


Innovation and R&D

Innovation and R&D Innovation is a central theme for SS&C. It has invested heavily in R&D, with a strong focus on AI, automation, and cloud-native platforms. Examples include AI agents tailored for financial and healthcare workflows, the DealCentre AI platform in Intralinks, and expanded automation capabilities via Blue Prism. The company is pushing into generative AI, next-generation intelligent automation, and cloud-based wealth and healthcare platforms. It is also using acquisitions to bolster its technology stack and expand geographically, including in European wealth management. The key question going forward is how effectively these investments translate into new revenue streams, better margins, and deeper client relationships, while managing the complexity of an increasingly broad product set.


Summary

Overall, SS&C looks like a mature, growing software and services business with solid profitability, strong cash generation, and a meaningful competitive moat built on integration, switching costs, and scale. Revenue and operating profits have marched upward, even if net earnings have been somewhat choppy year to year. The balance sheet shows a leveraged but better-funded company than in the past, supported by rising equity and higher cash balances. Consistent free cash flow provides room to handle debt and continue investing. Strategically, SS&C is leaning hard into AI, intelligent automation, and cloud delivery while using targeted acquisitions to widen its footprint. The main opportunities lie in deepening its role as a critical operating backbone for financial and healthcare clients worldwide. The main risks center on competition, regulatory complexity in its end markets, and the ongoing execution challenge of integrating new technologies and acquired businesses without adding too much complexity or cost.